Filing Details
- Accession Number:
- 0001801170-25-000168
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-08 17:15:04
- Reporting Period:
- 2025-07-03
- Filing Date:
- 2025-07-08
- Accepted Time:
- 2025-07-08 17:15:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1801170 | Clover Health Investments Corp. | CLOV | Hospital & Medical Service Plans (6324) | 981515192 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1839066 | L. Jamie Reynoso | C/O Clover Health Investments, Corp. Not Applicable Wilmington DE 19801 | Ceo, Medicare Advantage | No | Yes | No | No |
Transaction Summary
| Sold: | 21,801 shares | Avg. Price: $2.60 | Total Value: $56,789.82 |
| Number of Shares After Transactions: | 3,297,821 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2025-07-03 | 19,789 | $2.58 | 3,308,539 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2025-07-03 | 8,706 | $2.56 | 3,299,833 | No | 4 | F | Direct | |
| Class A Common Stock | Disposition | 2025-07-07 | 2,012 | $2.85 | 3,297,821 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.54 to $2.63, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on July 3, 2025, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date.
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.81 to $2.88, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
